One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

Also this month, AstraZeneca announced it could pay up to $1 billion on a cash and debt-free basis for Belgian company EsoBiotec to advance its cell therapy ambitions. It has agreed to acquire all ...

Learn More. After rising by over 20% since November, the AstraZeneca (LSE:AZN) share price is on a good run. And now management has just signed a $1bn deal to acquire EsoBiotec and further secure ...

After rising by over 20% since November, the AstraZeneca (AZN.L) share price is on a good run. And now management has just signed a $1bn deal to acquire EsoBiotec and further secure its long-term ...

The companies expect the transaction to close during the second quarter of 2025. AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition EsoBiotec SA has entered into a ...

Wall Street's major averages closed in the green on Friday, and the benchmark S&P 500 (SP500) snapped a four-week losing streak after U.S. President Donald Trump said there might be some "flexibility" ...

GAITHERSBURG, Md. (DC News Now) — AstraZeneca is making a major push into cell therapy with the acquisition of EsoBiotec, a company that has developed a groundbreaking approach to fighting cancer. The ...

AZN to Acquire EsoBiotec; EU Nod for Imfinzi Expanded Use AstraZeneca announced a definitive agreement to acquire Belgium-based, EsoBiotec, a leading vivo cell therapy company for a total ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The UK ...

AstraZeneca has agreed to purchase Belgium-based EsoBiotec for up to $1 billion. The acquisition is aimed at enhancing AstraZeneca's cell therapy capabilities, with a focus on innovative cancer ...

Multinational pharmaceutical company AstraZeneca plc has entered into a definitive agreement to acquire the Belgian biotech company EsoBiotec. This is reported in a press release from AstraZeneca. The ...